SynthesisScientific reports2024
Dynamics of Mpox infection in Nigeria: a systematic review and meta-analysis.
Synthesis in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Mpox knowledge and perception in Africa: a systematic review and meta-analysis.BMC public health · 2026Pooled it
- Epidemiological and clinical characteristics of Peruvian patients with mpox: A systematic review and meta-analysis.PloS one · 2025Pooled it
- Mpox and the one health approach.Dialogues in health · 2026Review
- Mpox and the Ethics of Outbreak Management: Lessons for Future Public Health Crises.Developing world bioethics · 2026Article
- Mpox coinfections and clinical manifestation in Africa: a systematic review and meta-analysis.Frontiers in systems biology · 2026Review
- Serological evidence uncovers undocumented mpox exposure in febrile patients in Nigeria.Frontiers in public health · 2026Article
- A Comparative Analysis of Global Responses to Monkeypox Outbreaks: Lessons Learned and Future Directions - a Mini Narrative Review.Annals of medicine and surgery (2012) · 2025Review
- Time series modelling and forecasting of mpox incidence and mortality in Nigeria.BMC infectious diseases · 2025Article
- Risk perception and factors associated with the acceptance of smallpox vaccine against monkeypox among healthcare and healthcare support workers in Northeastern Nigeria.The Pan African medical journal · 2025Article
- Non-exanthematous mpox infections in Nigeria: a possible explanation of the sporadic outbreaks in city centers?The Pan African medical journal · 2025Article
- Mpox in endemic regions in Nigeria: awareness, knowledge, and willingness to accept the mpox vaccine.The Pan African medical journal · 2025Article
- Knowledge of Mpox among secondary school students in Nigeria: a cross-sectional study.The Pan African medical journal · 2025Article
- Article
- Mpox in a Neonate: A Case Report of a 14-day-old Baby in Nigeria.Nigerian medical journal : journal of the Nigeria Medical AssociationReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The seasonal outbreaks of Mpox continue in most parts of West and Central Africa. In the past year, Nigeria had the highest number of reported cases. Here, we used the PRISMA guidelines to carry out a systematic review and meta-analysis of available evidence on Mpox in Nigeria to assess the prevalence, transmission pattern, diagnostic approach, and other associated factors useful for mitigating the transmission of the disease. All relevant observational studies in PubMed/MEDLINE, Embase, AJOL, Web of Science, Scopus and Google Scholar on Mpox in Nigeria were assessed within the last fifty years (1972 to 2022). In all, 92 relevant articles were retrieved, out of which 23 were included in the final qualitative analysis. Notably, most of the cases of Mpox in Nigeria were from the southern part of the country. Our findings showed a progressive spread from the southern to the northern region of the country. We identified the following factors as important in the transmission of Mpox in Nigeria; poverty, lack of basic healthcare facilities, and risk of exposure through unsafe sexual practices. Our findings reiterate the need to strengthen and expand existing efforts as well as establish robust multi-sectoral collaboration to understand the dynamics of Mpox Nigeria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.